1.
Bioorg Med Chem Lett
; 15(22): 5012-5, 2005 Nov 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16154744
RESUMO
SAR and DMPK studies led to the identification of substituted N-alkyl-N-[1-(3,3-diphenylpropyl)piperidin-4-yl]-2-phenylacetamides as potent and orally bioavailable ligands for the human CCR5 chemokine receptor.